Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories : production of human alpha-galactosidase A

This work was supported by ERANET-IB08-007 project from the European Union and its linked national project EUI2008- 03610 to AV. We also appreciate the support from EME2007-08 to NFM from Universitat Autonoma de Barcelona, from Antartide 2010 to MLT and EP, from MIUR Azioni Integrate Italia-Spagna 2...

Full description

Bibliographic Details
Published in:Applied Microbiology and Biotechnology
Main Authors: Unzueta Elorza, Ugutz, Vázquez Lima, Felícitas, Accardi, Giulia, Mendoza, Rosa, Toledo-Rubio, Verónica, Giuliani, Maria, Sannino, Filomena, Parrilli, Ermenegilda, Abasolo, Ibane, Schwartz, Simo, Villaverde Corrales, Antonio, Corchero Nieto, José Luis, Ferrer-Miralles, Neus, Tutino, Maria L.
Format: Article in Journal/Newspaper
Language:English
Published: 2015
Subjects:
Online Access:https://ddd.uab.cat/record/132802
id ftuabarcelonapb:oai:ddd.uab.cat:132802
record_format openpolar
spelling ftuabarcelonapb:oai:ddd.uab.cat:132802 2023-05-15T14:17:02+02:00 Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories : production of human alpha-galactosidase A Unzueta Elorza, Ugutz Vázquez Lima, Felícitas Accardi, Giulia Mendoza, Rosa Toledo-Rubio, Verónica Giuliani, Maria Sannino, Filomena Parrilli, Ermenegilda Abasolo, Ibane Schwartz, Simo Villaverde Corrales, Antonio Corchero Nieto, José Luis Ferrer-Miralles, Neus Tutino, Maria L. 2015 application/pdf https://ddd.uab.cat/record/132802 eng eng Ministerio de Economía y Competitividad IT2009-0021 Ministerio de Economía y Competitividad EUI2008-03610 Agència de Gestió d'Ajuts Universitaris i de Recerca 2009/SGR-108 Applied microbiology and biotechnology Vol 99, Issue 14 (July 2015), p. 5863-5874 https://ddd.uab.cat/record/132802 urn:10.1007/s00253-014-6328-9 urn:oai:ddd.uab.cat:132802 urn:recercauab:ARE-78977 urn:articleid:01757598v99n14p5863 urn:scopus_id:84932198319 urn:wos_id:000356806300010 urn:oai:egreta.uab.cat:publications/245fa017-2d4b-4b73-92b5-0090c42d6b52 open access Tots els drets reservats. https://rightsstatements.org/vocab/InC/1.0/ Recombinant protein Expression systems Escherichia coli Pseudoalteromonas haloplanktis TAC125 Human alpha-galactosidase A Fabry's disease Article 2015 ftuabarcelonapb 2023-02-06T21:03:29Z This work was supported by ERANET-IB08-007 project from the European Union and its linked national project EUI2008- 03610 to AV. We also appreciate the support from EME2007-08 to NFM from Universitat Autonoma de Barcelona, from Antartide 2010 to MLT and EP, from MIUR Azioni Integrate Italia-Spagna 2010 Prot. IT10LECLM9 to MLT, from MINECO (IT2009-0021) to AV and LT, from AGAUR (2009SGR-108) to AV. AV is also supported by The Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN, Spain), an initiative funded by the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. PS has received predoctoral fellowship from ISCIII, and AV has been distinguished with an ICREA ACADEMIA award (Catalonia, Spain). Obtaining high levels of pure proteins remains the main bottleneck of many scientific and biotechnological studies. Among all the available recombinant expression systems, Escherichia coli facilitates gene expression by its relative simplicity, inexpensive and fast cultivation, well-known genetics and the large number of tools available for its biotechnological application. However, recombinant expression in E. coli is not always a straightforward procedure and major obstacles are encountered when producing many eukaryotic proteins and especially membrane proteins, linked to missing posttranslational modifications, proteolysis and aggregation. In this context, many conventional and unconventional eukaryotic hosts are under exploration and development, but in some cases linked to complex culture media or processes. In this context, alternative bacterial systems able to overcome some of the limitations posed by E. coli keeping the simplicity of prokaryotic manipulation are currently emerging as convenient hosts for protein production. We have comparatively produced a "difficult-to-express" human protein, the lysosomal ... Article in Journal/Newspaper Antartide Universitat Autònoma de Barcelona: Dipòsit Digital de Documents de la UAB Applied Microbiology and Biotechnology 99 14 5863 5874
institution Open Polar
collection Universitat Autònoma de Barcelona: Dipòsit Digital de Documents de la UAB
op_collection_id ftuabarcelonapb
language English
topic Recombinant protein
Expression systems
Escherichia coli
Pseudoalteromonas haloplanktis TAC125
Human alpha-galactosidase A
Fabry's disease
spellingShingle Recombinant protein
Expression systems
Escherichia coli
Pseudoalteromonas haloplanktis TAC125
Human alpha-galactosidase A
Fabry's disease
Unzueta Elorza, Ugutz
Vázquez Lima, Felícitas
Accardi, Giulia
Mendoza, Rosa
Toledo-Rubio, Verónica
Giuliani, Maria
Sannino, Filomena
Parrilli, Ermenegilda
Abasolo, Ibane
Schwartz, Simo
Villaverde Corrales, Antonio
Corchero Nieto, José Luis
Ferrer-Miralles, Neus
Tutino, Maria L.
Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories : production of human alpha-galactosidase A
topic_facet Recombinant protein
Expression systems
Escherichia coli
Pseudoalteromonas haloplanktis TAC125
Human alpha-galactosidase A
Fabry's disease
description This work was supported by ERANET-IB08-007 project from the European Union and its linked national project EUI2008- 03610 to AV. We also appreciate the support from EME2007-08 to NFM from Universitat Autonoma de Barcelona, from Antartide 2010 to MLT and EP, from MIUR Azioni Integrate Italia-Spagna 2010 Prot. IT10LECLM9 to MLT, from MINECO (IT2009-0021) to AV and LT, from AGAUR (2009SGR-108) to AV. AV is also supported by The Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN, Spain), an initiative funded by the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. PS has received predoctoral fellowship from ISCIII, and AV has been distinguished with an ICREA ACADEMIA award (Catalonia, Spain). Obtaining high levels of pure proteins remains the main bottleneck of many scientific and biotechnological studies. Among all the available recombinant expression systems, Escherichia coli facilitates gene expression by its relative simplicity, inexpensive and fast cultivation, well-known genetics and the large number of tools available for its biotechnological application. However, recombinant expression in E. coli is not always a straightforward procedure and major obstacles are encountered when producing many eukaryotic proteins and especially membrane proteins, linked to missing posttranslational modifications, proteolysis and aggregation. In this context, many conventional and unconventional eukaryotic hosts are under exploration and development, but in some cases linked to complex culture media or processes. In this context, alternative bacterial systems able to overcome some of the limitations posed by E. coli keeping the simplicity of prokaryotic manipulation are currently emerging as convenient hosts for protein production. We have comparatively produced a "difficult-to-express" human protein, the lysosomal ...
format Article in Journal/Newspaper
author Unzueta Elorza, Ugutz
Vázquez Lima, Felícitas
Accardi, Giulia
Mendoza, Rosa
Toledo-Rubio, Verónica
Giuliani, Maria
Sannino, Filomena
Parrilli, Ermenegilda
Abasolo, Ibane
Schwartz, Simo
Villaverde Corrales, Antonio
Corchero Nieto, José Luis
Ferrer-Miralles, Neus
Tutino, Maria L.
author_facet Unzueta Elorza, Ugutz
Vázquez Lima, Felícitas
Accardi, Giulia
Mendoza, Rosa
Toledo-Rubio, Verónica
Giuliani, Maria
Sannino, Filomena
Parrilli, Ermenegilda
Abasolo, Ibane
Schwartz, Simo
Villaverde Corrales, Antonio
Corchero Nieto, José Luis
Ferrer-Miralles, Neus
Tutino, Maria L.
author_sort Unzueta Elorza, Ugutz
title Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories : production of human alpha-galactosidase A
title_short Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories : production of human alpha-galactosidase A
title_full Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories : production of human alpha-galactosidase A
title_fullStr Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories : production of human alpha-galactosidase A
title_full_unstemmed Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories : production of human alpha-galactosidase A
title_sort strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories : production of human alpha-galactosidase a
publishDate 2015
url https://ddd.uab.cat/record/132802
genre Antartide
genre_facet Antartide
op_relation Ministerio de Economía y Competitividad IT2009-0021
Ministerio de Economía y Competitividad EUI2008-03610
Agència de Gestió d'Ajuts Universitaris i de Recerca 2009/SGR-108
Applied microbiology and biotechnology
Vol 99, Issue 14 (July 2015), p. 5863-5874
https://ddd.uab.cat/record/132802
urn:10.1007/s00253-014-6328-9
urn:oai:ddd.uab.cat:132802
urn:recercauab:ARE-78977
urn:articleid:01757598v99n14p5863
urn:scopus_id:84932198319
urn:wos_id:000356806300010
urn:oai:egreta.uab.cat:publications/245fa017-2d4b-4b73-92b5-0090c42d6b52
op_rights open access
Tots els drets reservats.
https://rightsstatements.org/vocab/InC/1.0/
container_title Applied Microbiology and Biotechnology
container_volume 99
container_issue 14
container_start_page 5863
op_container_end_page 5874
_version_ 1766288987697184768